Association between PAI-1 4G/5G polymorphism and diabetic nephropathy: a meta-analysis in the Chinese population
Autor: | Zhen-qi Wu, Ying-bo Guo, Xin-yu Ding, Wenfeng Gao, Yong-ji Yan, Yu Bai |
---|---|
Rok vydání: | 2016 |
Předmět: |
Nephrology
China medicine.medical_specialty Urology 030232 urology & nephrology 030204 cardiovascular system & hematology Diabetic nephropathy 03 medical and health sciences chemistry.chemical_compound 0302 clinical medicine Risk Factors Internal medicine Plasminogen Activator Inhibitor 1 medicine Diabetic Nephropathies Allele Alleles Chinese population Polymorphism Genetic business.industry Odds ratio medicine.disease Confidence interval Endocrinology chemistry Meta-analysis Plasminogen activator inhibitor-1 business |
Zdroj: | International Urology and Nephrology. 48:1483-1489 |
ISSN: | 1573-2584 0301-1623 |
DOI: | 10.1007/s11255-016-1333-9 |
Popis: | Although a number of studies have been conducted on the association between plasminogen activator inhibitor-1 (PAI-1) 4G/5G polymorphism and diabetic nephropathy (DN) in Chinese population, this association remains elusive and controversial. To further assess the effects of PAI-1 4G/5G polymorphism on the risk of DN, a meta-analysis was performed in the Chinese population. Relevant studies were identified using PubMed, Springer Link, Ovid, Chinese Wanfang Data Knowledge Service Platform, Chinese National Knowledge Infrastructure, and Chinese Biology Medicine through November, 2015. Pooled odds ratios (ORs) and 95 % confidence intervals (CIs) were used to assess the strength of the associations. This meta-analysis identified nine studies, including 777 DN cases, 413 healthy controls, and 523 DM controls. In the total analyses, a significantly elevated risk of DN was associated with variants of PAI-1 4G/5G when compared with the healthy group (4G vs. 5G, OR 2.46, 95 % CI 1.45–4.16; 4G/4G vs. 5G/5G, OR 4.32, 95 % CI 1.79–10.39; 4G/4G vs. 4G/5G +5G/5G, OR 2.96, 95 % CI 1.59–5.53; 4G/4G +4G/5G vs. 5G/5G, OR 2.78, 95 % CI 1.34–5.75) and DM group (4G vs. 5G, OR 1.93, 95 % CI 1.28–2.92; 4G/4G vs. 5G/5G, OR 2.99, 95 % CI 1.44–6.21; 4G/4G vs. 4G/5G +5G/5G, OR 2.84, 95 % CI 1.77–4.54). In the subgroup analyses stratified by ethnicity and geographic areas, it revealed the significant results in Chinese Han, in North and South China. This meta-analysis showed that the PAI-1 4G/4G variant, 4G allele might be risk alleles for DN susceptibility in the Chinese population, and further studies in other ethic groups are required for definite conclusions. |
Databáze: | OpenAIRE |
Externí odkaz: |